Not a Fund. The House It Lives In.

"Trivera is a pre-seed and seed fund investing across Israel, the UK, and DACH in AI-Native B2B solutions, HealthTech, and ClimateTech — leveraging our operator experience and cross-border relationships to support adoption and growth."

Most people raise a fund. We are building a firm: one team, one thesis, and one operating engine, designed to compound across a succession of funds over the next decade — and, in time, to replicate the same playbook into new corridors. Fund I is already live and deploying; the platform is being built around it now.

Three Verticals. Three Time Horizons. One Structural Tailwind

Trivera is a pre-seed and seed fund investing across Israel, the UK, and DACH in AI-Native B2B Solutions, as well as Health Tech, and Climate Tech startups - leveraging our operator experience and cross-border relationships to support adoption and growth.

All three are returns-first theses. The Trivera Score makes financial, human, and planetary contribution explicit — and it never overrides financial discipline.

Bottom-up: Trivera analysis based on 2024–2025 regional funding data from Beauhurst, KfW, EY and Startup Nation Central. Estimated ~1,500 pre-seed and seed rounds annually across Trivera’s three target verticals - AI-native B2B, Health Tech and Climate Tech - and three target geographies - Israel, the UK and DACH - generally at ≤$15M post-money. No single source reports this exact filtered dataset. References: Beauhurst, State of UK Investment H1 2025; KfW, VC Dashboard 2025; EY, Startup Barometers; Startup Nation Central, Israeli Tech Funding 2025.

1–3 Grand View Research, 2030 projected global market revenues: global AI - $1.8T; digital health - $1.5T; clean technology - $1.8T. Global AI is used as a broad market-opportunity proxy for AI-native B2B; figures do not represent Trivera’s directly addressable market. 4 Startup Nation Central - Israel holds one of the world’s highest startup densities; AI companies are ~30% of the ecosystem and draw ~47% of its funding. 5 Mordor Intelligence / EIT Health - Germany holds the largest share of Europe’s digital-health market and is Europe’s largest healthcare market. 6 Z/Yen Global Green Finance Index - London ranked the world’s #1 green-finance centre across five consecutive editions.

References to "why now" drivers and other market trends reflect Trivera's current views and assumptions only, are forward looking and are subject to change without notice; actual developments may differ materially.

The Engine Finds. Experience Guides. We Select.

An AI-native engine that runs a six-stage process — 400 companies assessed in its first six months, 3 backed — applying institutional-grade rigor to build Fund I's target portfolio of ~10 companies. The engine owns coverage; every decision is made by the three of us.

Three Operators. One Team. Local Presence in All Three Markets

A cross-border team that has built, scaled, and exited technology businesses - as founders, executives, and investors. All three partners work on Trivera as their primary professional commitment.

Saar Bargay

Co-Founder & Managing Partner

Founded and sold Asperii (acquired by Aman Group) - 25+ years building enterprise software, cybersecurity, and AdTech companies, from inception to acquisition

Began as a technology architect - deep in product architecture and defensible innovation; expertise in enterprise sales and the global Salesforce ecosystem

Led international expansion initiatives and high-stakes strategic transactions across the US, Europe, and Israel

Active angel investor and advisor - supporting founders on GTM, fundraising preparation, and international market entry

Michal Karnibad

Co-Founder & Managing Partner

25+ years building and scaling businesses across venture-backed, private-equity-backed, and public companies, as well as global technology and financial institutions such as PayPal, Citi, HSBC, Amdocs, and Tide

Former COO / Co-CEO of high-growth startups with expertise in M&A, enterprise GTM, software development, and AI transformation

Active angel investor; mentored dozens of startups through Zinc, Barclays Techstars, and Startupbootcamp
B.A. in Computer Science; MBA from the University of Michigan

Moshe Daniel

Co-Founder & Managing Partner

Former CIO & Deputy CEO of Ogen, Israel's leading fintech lending platform - led its digital and operational transformation through rapid growth

20+ years in institutional finance: private banker at Clariden Leu (Israeli desk); investment management at MMG Zurich

Established MMG Wealth, the group's Swiss family office

Active early-stage investor; evaluated hundreds of startups; deeply connected in the Swiss and Israeli ecosystems
Information Systems Engineering + M.A. in Law

The three of us have personally invested our own capital in ten startups as angels.

From First Check to Exit - Compounding Value

Capital, networks, and cross-border access compound at every stage - moving each portfolio company closer to its next round and, ultimately, a credible exit.

In Practice

Thermagix

Patented deep tech converting industrial waste heat - from ships, data centers, and plants - into usable power or cooling. TRL 4–5, two patents granted plus two PCT filings, five-plus LOIs - and a proof-of-concept running inside BAZAN's operating refinery. We invested via SAFE in July 2026 and brought additional co-investors into the round.

Unibloom

Brought additional co-investors into the round and hands-on GTM support.

Cross-Border GTM

The European Journey

Co-hosted a UK & Germany market-entry summit for HealthTech founders with R.S NESS Group and Munich MedTech.

This description of market trends and investment thesis reflects Trivera's current views and assumptions only, are forward looking and are subject to change without notice; actual developments may differ materially. This investment thesis is a goal only and does not constitute a promise, projection or guarantee of any particular outcome, and there can be no assurance that this investment thesis will be achieved or implemented as described. There is no assurance that the Fund will complete investments in accordance with this thesis or that any such investment, if completed, will be successful.

Four Funds. One Compounding Platform.

Each fund is built on the same engine, team, and thesis — and each one makes the next easier to raise. The long view: a Trivera franchise, with the same playbook replicated into new corridors in the decade ahead.

The firm-level entry exists once — now. By Fund II, this becomes an LP conversation.

Partner in the Firm — Not Just a Fund

We are opening a small number of strategic partner positions in Trivera the firm — not in a single fund. A strategic partner invests in the management company and participates in the economics of every fund the platform raises, starting with Fund I (live and deploying) and Fund II (forming) — sharing in the whole journey, not a single vehicle.

Designed for family offices and strategic individuals who want a position in a venture franchise at its founding — not a fund allocation.

• Ground-floor position in an emerging venture franchise, at the moment the platform is being built.
• Exposure to the whole engine — a strategic partner participates across the platform as it compounds, rather than betting on one fund's vintage.
• Alignment by design — the founding partners operate the firm for the life of its funds, and strategic partners sit on the same side of the table.
• A structured, transparent proposal — every element of the partnership is documented and open to review; we would rather you stress-test it with us than take anything on faith. The economics, the model, and the terms are shared directly, in a conversation.

Counsel: Meitar Law Offices  ·  Audit: EY  ·  Fund administration: Perryllion